Sales of products such as engineered wood, siding, millwork, outdoor living, industrial products and specialty lumber and panels, decreased $64 million or 11% to $504 million. The company said ...
German cosmetic and perfume retailer Douglas said sales in the second quarter of its fiscal year increased by 11.5%, with growth in all areas. The recently listed company said Monday that store ...
Shares of Medical Properties Trust climbed 11% to $4.43 in after-hours trading following news on the sale of its interests in five Utah hospitals to a new joint venture for $886 million.
In April 2024, the sales of new passenger cars increased by 11% year over year to more than 5,700 units. This follows from a statement by the Ukravtoprom association, the Ukrainian News Agency reports ...
Sales of digital music amounted to 116.5 billion yen (about US$752 million), a new record and an 11% increase year-on-year. This is the 10th consecutive year that sales have increased. The total ...
Indian automaker Tata Motors said on Monday its Jaguar Land Rover's fourth-quarter sales rose 11% from a year earlier to 114,038 units, driven by increased production and sustained global demand.
sales performance results showed 23% growth for comparable sales on top of last year’s 11%, expanding its market share by more than $1 billion. According to Brian Cornell, chairman and CEO of ...
U.S. retail sales in August were up 0.6% compared to July ... Santa Clara with a 29% increase, Atlanta with an 11% increase, and Pittsburgh with a 10% increase. However, Taylor Swift concert ...
Fast Retailing's (9983.T) , opens new tab operating profit in the three months through February likely rose 11% from a year earlier ... robust same-store sales performance across the Asia, India ...
All categories closed in green, with 2W, 3W, PV, Trac and CV growing on a YoY basis by 9.5%, 58.5%, 11%, 7% and 8% respectively, according to FADA. Analysts said commercial vehicles (CV ...
Novo Nordisk (NVO) stock was trading down Thursday despite strong first quarter results, beating Wall Street consensus, led by the blockbuster GLP-1s Ozempic for diabetes and Wegovy for weight loss.